Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof

US Patent 8906936 · Granted Dec 9, 2014

Estimated economic value: $75,000,000

Assignee

Inventors

View full patent text on Google Patents →